The analysis of affordability of medicines with the capillary stabilizing effect in Ukraine
DOI:
https://doi.org/10.24959/sphhcj.24.312Keywords:
affordability; price index; medicines; angioprotectorsAbstract
Aim. To analyze the range, price dynamics and affordability indicators of capillary stabilizing medicines at the pharmaceutical market of Ukraine for the period of 2020-2023.
Materials and methods. The study object was the indicators of price and consumption of medicines in the group “Angioprotectors” (ATC code C05) within 2020-2023. To analyze the availability of drugs with the capillary stabilizing action presented at the pharmaceutical market of Ukraine, data from the State Register of Medicines of Ukraine, on-line Compendium, as well as data from the drug market research of the “Proxima Research” system, such online resources as Apteki.ua, Tabletki.ua, Liky-control were used. To process the information, we used modern methods of analysis, in particular generalization and systematization of information, comparison and methods of mathematical and statistical calculations.
Results. According to the results of the structural analysis of the range of capillary stabilizing medicines in groups C05C A “Bioflavonoids” and C05C X “Other capillary stabilizing medicines”, it was determined that 10 INNs of medicines were registered at the pharmaceutical market of Ukraine. Most of the medicines in the study group (57%) were of domestic production. The medicines analyzed were presented in 9 dosage forms; among them tablets, capsules and gels predominated. Individual and aggregate price indices (PI) for group C05C were calculated, they were: PI 2021/2020 = 1.10, PI 2022/2021 = 1.15, PI 2023/2022 = 1.20. In general, during the study period, price increases were observed by about 50 %, and up to 80 % for individual items. An internal referencing of prices for capillary stabilizing medicines was conducted by 9 reference groups. Prices for medicines in the form of gels and ointments were compared for primary packaging, and for tablets and capsules – per unit of dosage form. The minimum, maximum and average prices in each group and for individual trade names were determined. The analysis of price liquidity indicators (Cliq) showed that most medicines had Cliq in the range from 0.0 to 0.5 or were slightly higher. Corvitin® (BCPP, Ukraine) had the highest solvency adequacy index Ca.s = 0.064. For other medicines of the study group in the form of tablets, capsules, and gels, Ca.s ranged from 0.001 to 0.03.
Conclusions. The analysis of the structure of the range of capillary stabilizing medicines at the Ukrainian pharmaceutical market within 2020-2023 has been performed. The indicators characterizing the price situation of these medicines and their affordability for patients have been calculated. According to the results of the study conducted, the indicators of the price liquidity and adequacy of solvency of medicines in this group are in the range of sufficiently high affordability throughout the period analyzed.
References
Patel, S. K., Surowiec, S. M. (2024). Venous Insufficiency. Available at: https://www.ncbi.nlm.nih.gov/books/NBK430975/
Azar, J., Rao, A., Oropallo, A. (2022). Chronic venous insufficiency: a comprehensive review of management. Journal of Wound Care, 31, 6. doi:10.12968/jowc.2022.31.6.510.
Ezberci, F., Ünal, E. (2018). Aesculus Hippocastanum (Aescin, Horse Chestnut) in the Management of Hemorrhoidal Disease: Review. Turkish Journal of Colorectal Disease. 28, 54-57. doi: 10.4274/tjcd.16442
Gallelli, L. (2019). Escin: a review of its anti-edematous, anti-inflammatory, and venotonic properties. Drug Design, Development and Therapy, 13, 3425–3437.
Zahaiko, A. L., Kukhtenko, O. S., Haluzinska, L. V., Bushyn, P. I. (2018). Eksperymentalne doslidzhennia protyzapalnykh vlastyvostei ekstraktu “Venosten”. Ukrainian biopharmaceutical journal, 2 (55), 17–20. doi: 10.24959/ubphj.18.174
Petrenko, I. (2021). Anhioprotektsiia yak dyferentsiiovanyi pidkhid do likuvannia khronichnoi venoznoi nedostatnosti. Health-UA.com, 9 (502), 28. Available at: https://health-ua.com/article/65832-angoprotektcya-yakdiferentcjovanij-pdhd-dolkuvannya-hronchno-venozno-nedost
Gloviczki, P. P., Lawrence, P. F., Wasan, S. M., Meissner, M. H., Almeida, J., , Brown, R. K. et al. (2024). The 2023 Society for Vascular Surgery, American Venous Forum, and American Vein and Lymphatic Society clinical practice guidelines for the management of varicose veins of the lower extremities. Part II: Endorsed by the Society of Interventional Radiology and the Society for Vascular Medicine. Journal of Vascular Surgery: Venous and Lymphatic Disorders, 12(1), 101670. doi: 10.1016/j.jvsv.2023.08.011.
Poliakova, D. S. (2020). Terapevtychnyi potentsial anhioprotektora Eskuzan®. Ukrainskyi medychnyi chasopys, 3 (137), 1–V/VI, 73-75. doi:10.32471/umj.1680-3051.137.181668
Iaroshenko, A. O., Shpychak, O. S. (2023). Doslidzhennia asortymentu ta obsiahiv prodazhiv kapiliarostabilizuvalnykh likarskykh zasobiv, predstavlenykh na vitchyznianomu farmatsevtychnomu rynku. Social Pharmacy in Health Care, 9, 3, 65–75. doi:10.24959/sphhcj.23.300
Nemchenko, A. S., Kukhtenko, O. S., Hladukh, Ye. V. (2017). Marketynhovi doslidzhennia rynku likarskykh zasobiv dlia likuvannia varykoznoho rozshyrennia ven ta zapalnykh zakhvoriuvan suhlobiv. Social Pharmacy in Health Care, 3, 3. 66-73. doi: 10.24959/sphhcj.17.87.
Tkachova O. V. Butko Ya. O., Pylypchatina N. V. (2018). Anhioprotektorni zasoby: doslidzhennia asortymentu ta sotsialno-ekonomichnoi dostupnosti. Suchasni dosiahnennia farmatsevtychnoi tekhnolohii i biotekhnolohii : zb. nauk. pr., 4, 249-252.
Fylypiuk, O. M., Kriukova, A. I., Vyshnevska, L. I., Hutnyk, D. V. (2020). Analiz farmatsevtychnoho rynku kapiliarostabilizuvalnykh zasobiv v Ukraini [Analysis of the pharmaceutical market of capillary stabilizing medicines in Ukraine]. Tekhnolohichni ta biofarmatsevtychni aspekty stvorennia likarskykh preparativ riznoi napravlenosti dii: mater. V Mizhnar. nauk.-prakt. internet-konf. Kharkiv : NFaU.
State register of medicines of Ukraine. Available at: http://www.drlz.com.ua/
Downloads
Published
Issue
Section
License
Copyright (c) 2024 National University of Pharmacy
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
